Spinal cord stimulation (SCS) Neurological

DTM™ SCS therapy
Spinal cord stimulation

DTM™ SCS is a proprietary, multiplexed algorithm coordinating multiple signals at multiple anatomical targets. In a randomized control trial (RCT) at 12 months, DTM™ SCS provided superior, sustained pain relief compared to conventional stimulation.1

DTM™ SCS endurance therapy

DTM™ SCS endurance therapy is an energy modified, differential target multiplexed therapy offering more longevity on Vanta™ recharge-free INS and rapid recharge on Intellis™ rechargeable INS. Results show meaningful pain relief, satisfaction and quality of life improvements at 12 months.2

Learn about Vanta™ SCS
Your advantage over pain

Vanta™ SCS gives you an advantage over pain. This high-performance, recharge-free device offers more longevity, DTM™ SCS endurance therapy, and unmatched MRI access.

Front view of the Medtronic Intellis device with AdaptiveStim technology, used for spinal cord stimulation therapy

Discover the
Intellis™ SCS platform

The Intellis™ SCS is the world’s smallest implantable neurostimulator. This high-performance rechargeable device offers unrivaled battery chemistry with >95% battery capacity at 9 years, personalized programming and unmatched MRI access.

Front view of Medtronic Intellis AdaptiveStim device

Reimbursement coding

Download
resources.

View Tools

MRI resources

Find MRI information
and resources.

Find Resources

Continuing  education

Access e-learning content on Medtronic Academy.

Visit Medtronic Academy
1

Fishman M, Cordner H, Justiz R, et al. 12-Month results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021. doi: 10.1111/papr.13066.

2

Provenzano, Peacock, Fishman, et al. A prospective multi-center study of reduced-energy DTM™ stimulation derivative: long-term outcomes in therapy-naive patients. Poster presented at: American Society of Regional Anesthesia and Pain Medicince (ASRA) Annual Pain Medicine Meeting: Nov. 17-19, 2022; Orlando, FL, USA.